FDA Approves Oxycodone with Abuse Deterrent – National Pain Report

The Food and Drug Administration has approved a new extended release version of oxycodone with an abuse deterrent formula. The drug, which will be marketed by Purdue Pharma under the brand name Targiniq ER, is only the second opioid painkiller with FDA approved labeling that describes its abuse deterrent properties.

Targiniq combines oxycodone with naloxone, a drug that is used to reverse (more…)

FDA approves new opioid pain reliever designed to be hard to abuse – Los Angeles Times

The U.S. Food and Drug Administration approved a new form of the powerful and controversial pain reliever OxyContin that is designed to be more resistant to abuse, but experts warned the drug could wind up having the opposite effect.

Purdue Pharma’s Targiniq ER combines a long-acting form of the opioid analgesic oxycodone with the medication naloxone, which is commonly used to reverse (more…)

FDA approves oxycodone painkiller designed to prevent drug abuse – Tech Times

Prescription drug overdoses

New formulation of controversial pain killer oxycodone has added ingredient meant to reduce abuse of drug. If crushed and snorted or injected, euphoric effect is muted.
(Photo : CDC.gov)

The U.S. Food and Drug Administration says it has granted approval of a new formulation of a powerful but controversial pain relief drug intended to make it hard to abuse.

Targiniq ER from (more…)